TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

VISTAPHARM LLC

NeurologyOncologyGastroenterology
Generics

VISTAPHARM LLC is a generic drug manufacturer focused on Neurology, Oncology, Gastroenterology.

1992
Since
15
Drugs
-
Trials
395
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

MYCOPHENOLATE MOFETIL 2026-02-23
Labeling
ARIPIPRAZOLE 2026-02-18
DIGOXIN 2026-02-09
Labeling
DIGOXIN 2026-02-09
Labeling
NYSTATIN 2026-02-05
ACYCLOVIR 2026-01-22
Labeling
METHADONE HYDROCHLORIDE 2026-01-22
Manufacturing (CMC)
MYCOPHENOLATE MOFETIL 2026-01-14
Labeling
MYCOPHENOLATE MOFETIL 2026-01-14
Labeling
OXYCODONE HYDROCHLORIDE 2026-01-06
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Neurology 30%
1 drugs
Oncology 30%
1 drugs
Gastroenterology 30%
1 drugs
Ophthalmology 10%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

AbbVie big-pharma
Oncology, Neurology, Ophthalmology
Roche big-pharma
Oncology, Neurology, Ophthalmology
Bristol-Myers Squibb big-pharma
Oncology, Gastroenterology, Neurology
Takeda big-pharma
Oncology, Gastroenterology, Neurology
Pfizer big-pharma
Oncology, Gastroenterology